Skip to Primary Navigation

Skip to main content

FDA nominee backs vaccine safety, sidesteps abortion pill debate

A photo of Heidi Overton, nominee for FDA Commissioner, standing with a crowd of seated people behind her at her Senate Finance Committee nomination hearing
Photo: Tasos Katopodis/Getty Images

Kevin Kinsella

1 min read

FDA commissioner nominee Heidi Overton defended vaccine safety while declining to take firm positions on mifepristone reviews.

President Donald Trump’s nominee to lead the FDA faced pointed questions from senators on vaccine safety and abortion drug regulation during her confirmation hearing.

Heidi Overton, MD, PhD, the nominee for FDA commissioner, emphasized that vaccines currently approved in the United States meet the agency’s standards for safety and

, , , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience